SHH · 600488.SS
Tianjin Tianyao Pharmaceuticals Co., Ltd.
CN¥4.73-CN¥0.04 (-0.84%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.96% below the high.
Loading market information…
SHH · 603520.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang Starry Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang Starry Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥0.10 per share, paid semi-annual. The forward yield is 1.26% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zhejiang Starry Pharmaceutical Co.,Ltd.’s next earnings report is currently expected on Apr 28, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang Starry Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | Apr 29, 2025 | CN¥0.03 | CN¥546.00M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥4.73-CN¥0.04 (-0.84%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.96% below the high.
CN¥10.44+CN¥0.20 (+1.95%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.54% below the high.
CN¥7.16+CN¥0.06 (+0.85%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.89% below the high.
CN¥8.07+CN¥0.08 (+1.0%)
Beijing Beilu Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.09% below the high.
CN¥7.37-CN¥0.04 (-0.54%)
LanZhou Foci Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.12% below the high.
CN¥4.55-CN¥0.09 (-1.94%)
Jinhe Biotechnology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CN¥8.37CN¥0.00 (0.0%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.55% below the high.
CN¥9.84-CN¥0.10 (-1.01%)
Harbin Medisan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.9% below the high.
